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2Introduction
This collaborative agreement between Drs. Severs and
Keil began in 1981, arising from a continuing interest in
the issue of what, exactly, are the consequences of headward
fluid shifts during manned spaceflight. Such shifts were
recognized early by both U.S. and Soviet scientists because
of signs and symptoms referable to the head. Some of these
include disturbed vision, puffiness in the face and peri-
orbital areas, headache, vestibular dysfunction and
distended jugular veins.
We posited that the fluid shift had an (a) immediate
effect on the brain and (b) a long-term action requiring a
neural interpretation of the flight environment. This would
re-adjust both efferent neural as well as hormonal
mechanisms to sustain cardiovascular and fluid/electrolyte
balance consonent with survival in microgravity.
This report summarizes work along these lines. Dr.
Severs was primarily responsible for physiological, and
Dr. Keil the biochemical and analytical aspects of the
experiments. Historically, the research began under NASA
grant NSG2122 to Dr. Severs but was converted to a
cooperative agreement to better reflect the fact that both
the research and publications were, indeed, collaborative.
For continuity, this report includes an appendix that lists,
separately, prior NSG2122 publications and NCC-2-127
sponsored research. Older NSG2122 work is not discussed;
only a synopsis of some of the main NCC-2-127 research is
presented. Since the main research findings are published
in the open literature, this synopsis is unreferenced,
except for numbers that refer readers to the NCC-2-127
publications list for detailed information about the
sponsored research.
Angiotensin and Vasopressin Actions in the CNS
The transition from the older NSG2122 grant to the
present (NCC-2-127) cooperative agreement continued our
original work on the concept that the peptide, angiotensin,
altered blood pressure and hydration by central nervous
system mechanisms. It is important to note that alterations
in the renin-angiotensin-aldosterone system were recognized
early in human spaceflight experience. However, in the mid
1970's, angiotensin was considered to act solely in the
periphery. Neural actions were considered not to occur in
normal physiology because the peptide should not cross the
blood-brain-barrier.
For purposes of clarity, it should be stated that it is
now known that all components of an independent renin-
angiotensin system are present in the brain. The mRNA's for
renin and it's substrate have been isolated from brain, and
two receptor subtypes have been identified. Much of the
biology evoked by angiotensin in the brain, like the blood-
borne peptide, involves control of blood pressure and
salt/water balance. Thus, it is apparent that both the
brain and kidney renin-angiotensin systems must work in an
integrated manner to achieve physiological homeostasis.
4Since early flight biomedical data documented that the
peripheral system was altered, it was necessary to evaluate
brain angiotensin activity to see how it would adjust. A
review of central vs peripheral angiotensin biology may be
found in publication [3].
Similarly, in the case of vasopressin, early biomedical
flight data provided evidence for diuresis and altered
vasopressin actions. This peptide was considered to be
acting solely on the kidney by way of the bloodstream.
However, evidence that the peptide was endogenously present
in multiple brain regions related to cardiovascular
regulation and water balance necessitated an analysis of its
central actions. Some specific questions and experiments
supported by NCC-2-127 in the area of angiotensin and
vasopressin activity in the CNS follows.
i. CSF Sodium Concentration as a Sensed Variable
Professor Bengt Andersson (Stockholm) had put forth the
hypothesis that drinking behavior (water intake) and
vasopressin (antidiuretic hormone) release was dependent on
a rise in the sodium concentration of cerebrospinal fluid
regardless of whether the afferent signal was induced by
osmotic or volume mechanisms. Part of this hypothesis was
based on the pronounced drinking behavior and vasopressin
release evoked by small amounts of angiotensin in brain.
We developed a specific test of this hypothesis using
conscious rabbits fitted with a sodium selective electrode
in a lateral cerebral ventricle to provide continuous, on-
line recording of CSF [Na+]. When exposed to either
"volume" or "osmotic" stimuli, drinking and vasopressin
release occurred without a rise in CSF [Na+]. It remains
possible that Na + flux in brain cells is a common signal,
but comcemtratiom of the ion is not. An additional
important observation made during these studies was that CSF
renin activity increases after a hypertonic sodium chloride
stimulus. This is opposite to plasma, where renin activity
decreases. This was an important point in developing the
concept that some central vs peripheral actions of
angiotensin were reciprocal. Also, to the best of our
knowledge, these were the first experiments to continuously
monitor CSF [Na +] in comscious animals. Reference # 1
provides details of method development and logistics.
2. Redundancy in Vasopressin Release
Literature in the early 1980's began to focus on the
importance of angiotensin in the release of vasopressin.
There was uniform agreement that small amounts of the
peptide released vasopressin after instillation into
cerebrospinal fluid. Like CSF [Na +] referred to above, a
central action of angiotensin was perceived as a link for
both volume and osmotic release of the hormone. Specific
experiments were designed to block angiotensin receptors in
the brain before rehydrating comscious water-deprived rats.
This form of dehydration activates both volume and osmotic
control systems. Using protocols that clearly blocked the
activity of exogenous angiotensin, rats were able to re-
hydrate properly when receptors for the peptide in the brain
were blocked. Thus, mechanisms for rehydration have
sufficient redundancy and angiotensin activity is not an
absolute necessity. Intuitively, it makes physiological
sense not to encode the response to dehydration to a single
molecule (sic - angiotensin) without backup mechanisms. Our
work provided documentation of this point (reference 7).
3. Mechanism of Angiotensin Natriuresis
One unexplained central effect of angiotensin that was
the mechanism of natriuresis. Renal hemodynamics had been
ruled out as an explanation. Two additional possible
mechanisms were tested: mediation by renal nerves, or by a
central action of vasopressin. These were evaluated in
conscious rats given central injections of renin with or
without concomittant vasopressin, and with or without intact
renal nerves. Both of the possible explanations were ruled
out (reference 2). Subsequently, later research determined
that the most likely explanation was release of atrial
natriuretic peptide.
4. Endogenous Opiate Interaction with Angiotensin
These studies were a continuance of work from past
NSG2122 studies that showed that enkephalins and endorphins,
given centrally, inhibited the cardiovascular and hydration
responses to centrally administered angiotensin.
Experiments with conscious rats were performed using various
combinations of enkephalin pretreatments followed by central
angiotensin injections. Collectively, this work revealed
that enkephalin receptors reached from the third
cerebroventricle inhibited the angiotensin-induced rise in
blood pressure, drinking behavior and vasopressin release.
Opiate receptors reached from the fourth cerebroventricle
were only capable of reducing drinking behavior. (See
reference i0).
5. Vasopressin in the Subfornical Organ (SFO)
The SFO is clearly a site of action of angiotensin that
is reached from the blood and evokes drinking behavior and
vasopressin release. Also, the SFO normally contains
vasopressin that is packaged in ,,Hering-like" bodies similar
to the storage of vasopressin in the neural lobe of the
pitutitary. We studied whether vasopressin concentration in
the SFO changed after water deprivation or stimulation by
exogenous renin in a manner similar to the posterior
pituitary. The intent was to see if vasopressin, of SFO
origin, transduced the signal provided by angiotensin or
dehydration into water intake and renal water conservation.
The data obtained revealed that water deprivation increased
[vasopressin] in the nearby hippocampal-fornix area, but not
in the SFO body. Thus, if the neuronal elements of SFO use
vasopressin for signal transduction, its content is not
depleted by prolonged stimulation in a manner similar to
vasopressin in the posterior pituitary gland. Reference 15
provides detailed information about this research activity.
6. CSF Neurochemical Concentration vs Blood Pressure
Angiotensin and vasopressin, under appropriate
experimental conditions, raise blood pressure by actions on
the central nervous system. Altered concentrations of these
peptides, as well as many other neurochemicals and ions,
have been proposed as a potential etiologic factor in
elevated blood pressure. An experiment was designed to
assess whether or not elevated concentration of
neurochemicals in general was associated with high blood
pressure.
The specific experiment utilized 3 groups of conscious
rats: bilateral renal arterial stenosis of 30 days duration
(chronic); sham-operated control rats, and unoperated
control rats. The rats underwent a 5 hr cerebroventricular
infusion of either artificial cerebrospinal fluid or glass
distilled water at a rate of 2 ul/min followed by a 2 hr
recovery period. Blood pressure was recorded from an
indwelling carotid catheter and water intake and water and
salt excretion were measured.
Blood pressures of the sham-operated and unoperated
control rats were similar and both were much lower than the
hypertensive rats. Neither solvent affected blood pressure
when infused into the brain at any time over the 5 hr
experiment. On the other hand, water infusion into the
brain resulted in a clear diuresis and loss of free water in
all groups. Since the infusion of small volumes of water
promoted free water clearance it is likely that CSF dilution
occurred; however, this did not affect central control of
blood pressure in either normotensive rats or rats whose
blood pressure was elevated by neurogenic mechanisms.
Reference 4 describes the experiment in more detail.
7. Central Vasopressin and Peripheral Hydration
Various experiments reported in the literature during
the 1970's suggested that vasopressin, acting centrally,
altered drinking behavior and/or decreased peripheral
actions (i.e., change free-water clearance). Earlier
experiments (supported by NSG2122) revealed that acute
central injections of the peptide or its antiserum did not
acutely affect consummatory behavior or urine output.
However, since the half-life of vasopressin in CSF is about
20 min, potential longer term effects were uncertain. A
series of experiments was done in conscious rats where the
peptide was infused centrally for 5 hours or 5 days.
Consummatory behavior and water and electrolyte excretion
were measured. Vasopressin was without effect even though
some of the dose levels were sufficient to "spill over" into
plasma. Interestingly, in these cases, high plasma
vasopressin did not reduce water excretion; this finding
was subsequently confirmed in the literature.
Thus, high titers of vasopressin in CSF do not appear
to affect consummatory behavior or salt/water excretion. On
the other hand, similar types of experiments with the
peptide revealed other significant biological effects,
including memory processing, thermoregulation and
intracranial pressure (see below). Reference 5 provides an
i0
overview of vasopressin actions on consummatory behavior and
urine excretion.
8. Seizures Evoked by Central Vasopressin Injections
Periodical reports in the literature have described
acute seizures in conscious rats receiving central
injections of vasopressin. This was generally regarded as
some sort of nonspecific toxic reaction, as it occurred
unpredictably and seemed to be indpendent of dose. We
encountered this phenomenon, known as "barrel rotation" (BR)
in the literature, during our studies on central effects of
vasopressin dealing with salt/water balance and CSF
pressure. An attempt was made to define this unique motor
abnormality characterized by progressive ataxia, body
swaying, lying on one side with spastic limb abduction and
then rotation about the long axis of the body (BR).
A series of experiments was done where vasopressin was
injected intracerebroventricularly to conscious rats to
characterize this phenomenon. References 21, 22 and 27
should be consulted for full technical details. Here, a
summary of major scientific points that emerged is
presented.
First, in the dose range of i00 ng - 1 ug, the peptide
produced an incidence of BR of about 50%. Latency analysis
of this all-or-none event revealed a non-normal
distribution. Hazard function evaluation indicated two
separate underlying processes. One of these was eliminated
in paradigms where rats could not use visual/vestibular
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mechanisms to compensate for the potential seizure. Also, a
process of "sensitization,, was noted. When rats were
retested with a smaller dose of vasopressin 2 days after the
initial exposure, 80% of the animals displayed BR; all of
the rats that were originally susceptible responded after
re-exposure, and the increased incidence involved
recruitment of rats that were previously resistant to motor
destabilization. Antiseizure drugs of widely diverse
chemical classes all had some protective effect against
vasopressin-induced BR. Studies of regional cerebral
glucose utilization revealed modest increases or decreases
in brain sites that include areas related to
visual/vestibular systems.
Research on this subject was stopped when Dr. Keil was
advised that exploring these novel findings was outside of
the scope of the RTOP for salt/water balance. However,
further research into this area, not supported by NASA, has
led to good documentation that BR is an excellent model of
centrally mediated vestibular dysfunction, with similarities
to "space sickness" (see Pharmacological Reviews 41:53-90,
1989 for an analysis of this area of research).
Intracranial Pressure Control
This section highlights several experiments done on
intracranial (cerebrospinal fluid) pressure control. Three
principal reasons for studying this subject exisited at the
time this cooperative agreement began. Firstly, with regard
to the issue of cardiovascular and fluid/electrolyte changes
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in spaceflight, we considered that thoracic fluid shifts
might raise intracranial pressure and therefore, the brain
itself might provide the sensory component for compensation.
Secondly, information in the literature that indicated that
vasopressin in the CNS was associated with intracranial
pressure. Thirdly, our hydration studies with centrally
administered angiotensin revealed that conscious rats
equilibrated with hypotonic plasma and reduced body mass.
If saline was provided as a drinking fluid, rats tended
towards the same state but fluid drinking and turnover was
greatly increased. From a behavioral point of view, water
drinking after angiotensin resulted in a more rapid
equilibrium compared to saline-drinking, which was almost a
constant behavior. Although plasma was hypotonic, we could
not distinguish whether the brain was compensating for a
perceived hypertonic or a hypervolemic condition. If the
latter were a viable option, a rise in CSF pressure (CSFp)
could be anticipated before compensation. The experiments
described below highlight some of our achievements in this
area.
i. Acute Effects of Angiotensin and Vasopressin on CSFp.
The above comments prompted an assessment of whether
angiotensin and vasopressin acted centrally to change CSFp.
A method and protocol was established using conscious rats
that received a cerebroventricular infusion of artificial
CSF for 30 min, followed by a "switch" for 30 min to
artificial CSF with or without a peptide addition. Blood
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and CSF pressures were measured. The following main points
emerged. First, blood and CSFp's were similar and stable in
all groups during the control 30 min. During the second 30
min (experimental) interval, CSF and blood pressures
remained stable with infusions of artificial CSF or
vasopressin. However, angiotensin produced both a centrally
mediated rise in blood pressure and also raised CSF pressure
from about i0 to 16 cm H20. When the two peptides were
infused simultaneously, the rise in CSFp did not occur.
Thus, vasopressin did not affect CSFp of normal rats, but
was capable of blocking the newly discovered angiotensin-
stimulated increase. Reference ii provides details and
additional data. To our knowledge, this was the first
demonstration that high angiotensin levels in CSF elevated
intracranial pressure.
2. Peptide Effects on CSFp over a 5 Hour Interval
Because the experiment described above yielded positive
results showing that angiotensin infusion into CSF acutely
raised CSFp, it was necessary to define the time course of
this effect. The experiments to be summarized here employed
comscious rats prepared for continuous infusions and
pressure recordings from a lateral cerebroventricle over a 5
hr period. The details of these experiments are in
references 20 and 25. It is important here to note that the
infusion rate was 2 ul/min which is 100% of the endogenous
synthesis rate of CSF in rats. It is also important to note
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that, in the absence of obstructions to CSF drainage, CSFp
is essentially independent of the rate of volume input.
The main findings from these experiments are as
follows. First, angiotensin raised CSFp within 15 min,
which peaked by 60 min and remained elevated for the
remainder of the experiment. An important new observation
however, was that the artificial CSF, by itself, caused an
exponential rise in CSFp after a 2 hr lag, so that CSFp of
the "control" and angiotensin groups were equal by 4 hr.
The solvent-induced rise cannot be explained by volume
overload, because when vasopressin was contained in the
infusate, the rise in CSFp was markedly blunted. Also, when
the infusate contained the angiotensin receptor antagonist,
sarl-ile8-angiotensin II, the solvent effect was also
markedly reduced.
Collectively, the data suggested (a) that some normal
component(s) of CSF was required for pressure regulation and
was "washed out" by prolonged infusions, and (b) angiotensin
and vasopressin accelerated and inhibited the solvent-
induced rise, respectively. Here, it should be pointed out
that information from the literature documented that CSF
vasopressin concentrations are elevated in humans with
elevated intracranial pressure, regardless of the clinical
cause. This includes the disease, benign intracranial
hypertension (pseudotumor cerebri), where CSFp is elevated
with no known clinical reason. Based on the above
information, we undertook experiments to define what is
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"control" or "normal" CSFp, and the general mechanism that
elevates CSFp after infusions of a balanced, isotonic
sterile salt solution (i.e., artificial CSF).
3. 24 Hour CSFp Monitoring & the Solvent Effect
The series of experiments highlighted here deal with
the issues stated immediately above. Details of method
development and quantitative information are contained in
publications 29, 32, 36, and 45.
A method was developed to continuously record CSFp from
conscious, relatively unrestrained rats over a 24 hr period
using a computer-based system that sampled pressure every
second. One of the major technical problems that occurred
was that the choroid plexus often formed a seal around the
probe tip that occluded pressure recording. For this
reason, many experiments used an initial infusion of 8
ul/min for i0 min, followed by a continuous maintenance
infusion of 0.5 ul/min to keep choroidal tissue from sealing
the probe. In some of the experiments, the volumes of the
inital and maintenance infusions were divided in half and
infused into each lateral ventricle separately. Here, we
will summarize the results from 3 groups of rats: uninfused
rats where technical recording of CSFp was spontaneously
obtained over 24 hr without exogenous infusions, unilateral
infused rats that received the initial and maintanance
infusions into one lateral cerebroventricle, and bilaterally
infused rats where the exogenous infusions were equally
divided into both lateral cerebroventricles.
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Uninfused rats show a circadian rhythm in CSFp; it
begins to rise in the late afternoon and peaks at night.
Overall, normal pressure varies about two-fold over a day.
Pressure can be visually correlated with the activity of the
rat. For example, when a rat rears, or chews solid food,
etc., CSFp (relative to the transducer dome) rises. It is
interesting to note that blood pressure and vasopressin
concentration in CSF show a similar circadian rhythm. We
constructed an operational definition of "normal" CSFp to
compare uninfused rats with those that required an exogenous
infusion of artificial CSF to keep the recording lines open.
The integrated 24 hr CSFp and S.D.of each uninfused rat was
defined as 100% ± S.D. No uninfused rat ever had a CSFp
more than 2 x it's S.D. and maintained it at that level for
2 consecutive hours.
Rats that received infusions were the same as uninfused
rats for 2 hr. At that time, an exponential rise in CSFp of
the general form, f(t) = A + B * (i - e -t/c ) occurred. In
the unilateral group, a peak was reached at 4 hr, and CSFp
remained "abnormally elevated" according to the above
definition for the rest of the 24 hr experiment. CSFp
reached a peak at about 8 hr in the bilateral group; their
CSFp's were higher than the unilateral group and also met
the definition of "abnormally elevated". All infusions
abolished the circadian rhythm in CSFp observed in uninfused
rats. Rats receiving bilateral infusions differed from
those receiving unilateral infusions in that neurological
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symptoms were observed in 5 of 13 animals of the former
group vs 0 of 12 of the latter (p < 0.05). Also,
bilaterally infused rats drank less water over the 24 hr
period compared to unilaterally infused animals.
Thus, the following questions emerged, a/ Why did the
pressure curves of unilaterally and bilaterally infused rats
differ when the infused volume was the same? b/ Aside from
the initial infusion to clear the choroid, the 0.5 ul/min
maintenance infusion was only 25% of the endogenous CSF
synthesis rate. What happened in the 2 hr lag period that
caused infused rats to develop abnormally elevated CSFp for
the remainder of the experiment?
Alterations in the basic method were made to permit
bolus injections during cerebroventricular infusions and
pressure recordings. Estimates of compliance (C) and
resistance to outflow (Ro) could be calculated from the
decay kinetics. The following major findings emerged from
this aspect of the work.
a/ It was found that the initial i0 min infusion to
move the choroid away from the recording tip was, by itself,
a sufficient stimulus to evoke the delayed rise in CSFp.
The infusion, in our hands, duplicates data in the
literature, showing a moderate increase in CSFp during the
infusion and rapid recovery when the pump is turned off.
Even without a maintenance infusion, the exponential rise in
CSFp between hrs 2 and 4 occurred.
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b/ In unilaterally infused animals, Ro and C were
unchanged from baseline values during the 2 hr lag period.
However, when CSFp was elevated, Ro was increased and C
decreased.
c/ A protocol was used to inhibit CSF synthesis in
rats receiving the i0 min initial infusion. This blocked
the rise in CSFp that normally occurred from hrs 2 to 4.
However, the infusion still caused a rise in Ro and a
decrease in C. Since the effect of infusion on CSFp and Ro
could be dissociated, we proposed that the infusion exerts a
primary effect on mechanisms controlling Ro. CSFp rises
with time only if normal CSF synthesis continues. The model
has been proposed as a new method of studying abnormally
high CSFp in conscious, non-traumatized and relatively
unrestrained rats (see reference 45).
4. Other Studies on CSFp Control
a/ Conscious rats were gently restrained and their
CSFp's were continuously monitored during a 3 hr period.
The first hour was in the level position, the second hour
was in a -45 ° position, and the third hour was a recovery
period. The data obtained revealed that the overall CSFp
during the head-down tilt position was essentially normal.
Only a small, transient (5 min) effect occurred when the
tilt was initiated. Thus, under these conditions,
intracranial pressure can quickly compensate and does not
reach pathological levels. (See reference 43).
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b/ The vena cavae of rats were constricted about 50%
as they enter the heart or were left loosely tied. CSFp of
the animals was measured in the immediate post-operative
period, 1 and i0 days later. Terminal plasma [Na+], [K+],
[AVP] and hematocrit were measured, as well as drinking and
urine output from days 8 - i0. The intent of this
experiment was to try to simulate thoracic volume overload
by reducing rate of venous return of blood from the upper
body to the heart. Conceptually, this should also reduce
the venous/CSF pressure gradient that is the basis for CSF
drainage at the arachnoid villa.
The results of the experiments showed that the measures
listed above were similar (p > 0.05) for the sham operated
and the venous-constricted rats. Thus, like the head-down
tilt experiment described above, this experiment also showed
that intracranial pressure, as well as indices of salt/water
balance, rapidly adjust to conditions where a sudden fluid
shift to the thorax may be expected to occur. (See
reference 42 for details of this research)
c. Angiotensin or artificial CSF was infused into
conscious rats at a rate of 2 ul/min in a protocol similar
to that described above for 5 hour experiments. In these
specific experiments, bolus injections were superimposed so
that C and Ro could be calculated. The main result was that
angiotensin increased CSFp without a change in Ro. Since it
is unlikely that the peptide could stimulate synthesis by a
sufficient magnitude to rapidly raise CSFp, the only general
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mechanism remaining would be a rise in vascular volume. We
note here that, almost simultaneous with our work, a German
group found that angiotensin, acting from receptors reached
from CSF, markedly dilated pial arteries by a nitric oxide
dependent mechanism. This provides an explanation for our
discovery of the angiotensin-stimulated rise in CSFp. Our
experiments and the German data appear in publication 44.
d. Anesthetized rhesus monkeys were prepared for
intracranial pressure recordings during two simulations of
microgravity: -6 ° head-down tilt and water immersion. The
basic results were that during the relatively brief stimuli,
intracranial pressure rose significantly (p < 0.05) and
recovered rapidly after the stimulus was removed. The
reasons why anesthetized monkeys showed an acute response
whereas simulations described above for conscious rats did
not are unclear. However, it should be noted that the rise
in intracranial pressure in monkeys was relatively modest
and did not appear to be in a pathological range. The
experiment is described in reference 47.
Research on the Subcommissural Organ
Research beginning in the early 1980's provided clear
evidence that the brain contained receptors for
mineralocorticoids, but there was no information about the
biological output of mineralocorticoid actions in the brain.
Historically, the subcommissural organ (SCO) was associated
with aldosterone secretion from the adrenal cortices. Also,
flight data revealed increases in aldosterone secretion. We
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designed experiments to examine whether aldosterone exerted
central effects that could help explain salt/water balance
changes observed in flight. References 14 and 26 contain
the original data.
The general strategy was to continuously infuse
aldosterone or solvent locally into the SCO region of
conscious rats for six days and monitor consummatory
behavior and urinary volume and electrolyte excretion.
Terminal plasma samples were also assayed for ions and
hormones.
Collectively, the following main points were found.
i. Aldosterone produced a biological effect opposite to its
classical activity as a blood-borne hormone. Whereas the
classical function is to cause sodium retention by the
kidneys, aldosterone acted in the general region of the SCO
to increase sodium excretion from the body as well as the
urinary Na +/K+ ratio.
2. Contrary to what would have been predicted by classical
feedback endocrinology, central administration of
aldosterone did not affect the morphology of the adrenal
cortex or its zones, but produced a clear reduction in the
cross-sectional area of the adrenal medulla with no change
in the density of chromaffin cells. Paradoxically, this
central action of aldosterone was correlated with a specific
increase in plasma epinephrine concentration at the end of
the experiment. Norepinephrine and dopamine levels were
unaffected. It is important to note that these effects were
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more circumscribed than those affecting sodium excretion.
The adrenal effects required high precision in the SCO
cannula placement, whereas natriuresis occurred if cannulae
were slightly rostral (but not caudal) and confluent with
CSF of the pineal recess. However, the main pineal body was
excluded as a site of central aldosterone action in these
experiments.
Comparative studies were done by infusing aldosterone
directly into a lateral cerebroventricle. Under these
conditions, none of the effects evoked from the SCO area
occurred. However, the ventricular route of administration
revealed a clear reduction in consummatory behavior.
To the best of our knowledge, these studies were the
first to document that brain mechanisms controlling
salt/water balance and consummatory behavior were responsive
to aldosterone, and clearly establish that the brain is a
target organ of mineralocorticoids.
Research on the Eye
Simulations of headward fluid shifts such as head-down
tilt in humans raises intraocular pressure, which gradually
returns toward normal. There are many similarities between
issues associated with pressure volume relationships and
salt/water balance within the eye and brain. The tissues
which secrete and drain CSF and aqueous humor are remarkably
similar on a histological basis. Therefore, as our work on
CSFp control was developing, we also evaluated whether
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neuropeptides affected intra-ocular pressure (IOP). One
publication has appeared (35) and a working draft of our
physiological data is in manuscript form and available from
Dr. Keil (NASA-Ames) at the time of submission of this
report.
Here, we summarize the main biological findings.
First, we attempted to determine whether 3 major peptides
known to affect CSF pressure were present in ocular tissue.
These were angiotensin (ANG), vasopressin (AVP) and atrial
natriuretic peptide (ANP). There was diffuse immunostaining
for AVP and ANG in the uvea and retina in rats and rabbits.
ANP, however, was sharply localized in the inner and outer
plexiform layers of the retina but could not be localized in
anterior structures of the eye.
All three peptides were identified in both the ciliary
body/process and retina by sensitive radioimmunoassays.
ANG, AVP and ANP (anterior eye only) may be stored in a
manner unrecognized when the same antibodies were used for
the immunohistochemical analysis. Perfusion of eyes with
transcardiac phosphate buffered saline before collecting
tissue for radioimmunoassay did not affect the amount of ANP
or AVP measured in eye structures. This indicates that they
did not originate from blood contamination and were not
easily washed out of the eye. On the other hand, perfusion
completely washed ANG out of the eye. This, and other
published data lead to the conclusion that endogenous
angiotensin in the eye is made and used locally. In the
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case of all 3 peptides, the content in the ciliary
body/process greatly exceeded the content in the retina on a
wet weight basis. These experiments clearly established
that the 3 neuropeptides are endogenously present in the
eye. Since they are regulators of blood pressure and
salt/water balance, as well as influence CSF pressure,
analysis of their physiological effects in the eye was
undertaken.
The physiological experiments wee done by direct
pressure recording from the anterior chamber of the eye of
anesthetized rats. Potential peptide effects on IOP were
evaluated by 3 routes of administration (IVT, i.v., and
direct infusion into the anterior chamber). Under the
conditions used, central injections of active doses of the 3
peptides did not alter IOP. Equipressor doses of i.v. ANG
raised, whereas AVP decreased IOP. The direct infusion
studies revealed a novel finding. Similar to our studies
with CSFp, low volume infusions into the anterior chamber of
solvent (artificial CSF) raised IOP after a lag of 20 min.
Co-infused ANG or ANP reduced this solvent effect, but AVP
was markedly inhibitory. None of the peptides had an acute
effect on baselime IOP when directly infused. The action of
AVP was independent of aqueous humor formation, because it
occurred in rats pretreated with acetazolamide. The AVP
effect was reversed by a Vl-type receptor antagonist.
Superimposing bolus injections to determine resistance and
compliance estimates within the eye showed that AVP produced
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an acute increase in intraocular compliance. These novel
data suggest that baseline IOP may be maintained by
endogenous neuropeptides. Indeed, current literature is
available indicating that blockade of angiotensin activity
may lower IOP in animals and humans. Our data show that
development of Vl receptor antagonists capable of reaching
sites accessible from the anterior chamber may also have
salutory effects on abnormally high IOP. Currently, since
the co-operative agreement is terminated, we are completing
our analysis of the data base and are modeling the
pressure/volume dynamics of the eye and vasopressin-induced
alterations.
We speculate that routine monitoring of IOP of
astronauts during flight (a benign procedure) may be a
useful indicator of potential changes in CSFp. We posit
that there will be an initial rise, and that the rate of
recovery of IOP during flight may help predict how well
astronauts are adapting to the space environment, especially
during long missions.
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